ArticleFrontiers in oncology2021

Choosing the Right Treatment Option for the Right R/M HNSCC Patient: Should We Adhere to PFE for First-Line Therapy?

Katharina Lübbers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.